Meanwhile, fewer than 350 puts have traded, though that’s still 12 times the norm. Considering NBRV is a penny stock with limited downside potential, it’s not absurd to find such a heavy skew toward …
More FDA Nods Fuel Unsual Options Volume on NBRV, MRNA Videos